BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 4 hours ago Valaris Limited Drops 6.7% in Broad Selloff 6 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 6 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 6 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 6 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 7 hours ago Celanese Corporation Shares Dropping 5.5% 7 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 7 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 7 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 7 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 4 hours ago Valaris Limited Drops 6.7% in Broad Selloff 6 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 6 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 6 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 6 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 7 hours ago Celanese Corporation Shares Dropping 5.5% 7 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 7 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 7 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 7 hours ago
ADVERTISEMENT
Market News

The Scotts Miracle-Gro Company (SMG): Q4 2019 Earnings Snapshot

— The Scotts Miracle-Gro Company (NYSE: SMG) reported Q4 2019 loss of $0.91 per share, vs. a loss of $0.86 per share expected. — Sales grew 15% to $498 million, vs. $451 million expected. — FY20 sales is expected to grow 4-6%. — FY20 adjusted EPS is expected to be $4.95-5.15.  Get access to timely […]

November 6, 2019 1 min read

— The Scotts Miracle-Gro Company (NYSE: SMG) reported Q4 2019 loss of $0.91 per share, vs. a loss of $0.86 per share expected. — Sales grew 15% to $498 million, vs. $451 million expected. — FY20 sales is expected to grow 4-6%. — FY20 adjusted EPS is expected to be $4.95-5.15.  Get access to timely […]

— The Scotts Miracle-Gro Company (NYSE: SMG) reported Q4 2019 loss of $0.91 per share, vs. a loss of $0.86 per share expected.

— Sales grew 15% to $498 million, vs. $451 million expected.

— FY20 sales is expected to grow 4-6%.

— FY20 adjusted EPS is expected to be $4.95-5.15. 

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT